Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

503 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase I and pharmacologic study of irinotecan administered as a 96-hour infusion weekly to adult cancer patients.
Takimoto CH, Morrison G, Harold N, Quinn M, Monahan BP, Band RA, Cottrell J, Guemei A, Llorens V, Hehman H, Ismail AS, Flemming D, Gosky DM, Hirota H, Berger SJ, Berger NA, Chen AP, Shapiro JD, Arbuck SG, Wright J, Hamilton JM, Allegra CJ, Grem JL. Takimoto CH, et al. Among authors: cottrell j. J Clin Oncol. 2000 Feb;18(3):659-67. doi: 10.1200/JCO.2000.18.3.659. J Clin Oncol. 2000. PMID: 10653882 Clinical Trial.
Human plasma carboxylesterase and butyrylcholinesterase enzyme activity: correlations with SN-38 pharmacokinetics during a prolonged infusion of irinotecan.
Guemei AA, Cottrell J, Band R, Hehman H, Prudhomme M, Pavlov MV, Grem JL, Ismail AS, Bowen D, Taylor RE, Takimoto CH. Guemei AA, et al. Among authors: cottrell j. Cancer Chemother Pharmacol. 2001 Apr;47(4):283-90. doi: 10.1007/s002800000258. Cancer Chemother Pharmacol. 2001. PMID: 11345644 Clinical Trial.
A phase I and pharmacologic study of 9-aminocamptothecin administered as a 120-h infusion weekly to adult cancer patients.
Thomas RR, Dahut W, Harold N, Grem JL, Monahan BP, Liang M, Band RA, Cottrell J, Llorens V, Smith JA, Corse W, Arbuck SG, Wright J, Chen AP, Shapiro JD, Hamilton JM, Allegra CJ, Takimoto CH. Thomas RR, et al. Among authors: cottrell j. Cancer Chemother Pharmacol. 2001 Sep;48(3):215-22. doi: 10.1007/s002800100329. Cancer Chemother Pharmacol. 2001. PMID: 11592343 Clinical Trial.
Inflammation and IGF-I activate the Akt pathway in breast cancer.
Prueitt RL, Boersma BJ, Howe TM, Goodman JE, Thomas DD, Ying L, Pfiester CM, Yfantis HG, Cottrell JR, Lee DH, Remaley AT, Hofseth LJ, Wink DA, Ambs S. Prueitt RL, et al. Among authors: cottrell jr. Int J Cancer. 2007 Feb 15;120(4):796-805. doi: 10.1002/ijc.22336. Int J Cancer. 2007. PMID: 17096325
Explant organ culture: a review.
Resau JH, Sakamoto K, Cottrell JR, Hudson EA, Meltzer SJ. Resau JH, et al. Among authors: cottrell jr. Cytotechnology. 1991 Nov;7(3):137-49. doi: 10.1007/BF00365924. Cytotechnology. 1991. PMID: 1368116 Review.
Long-term culture of human esophageal explants and cells.
Resau JH, Phelps PC, Zhu SM, Smoot D, Lee HK, Cottrell JR, Hudson EA, Elliget KA. Resau JH, et al. Among authors: cottrell jr. Cytotechnology. 1990 Jan;3(1):61-73. doi: 10.1007/BF00365267. Cytotechnology. 1990. PMID: 1369997
503 results